Which COVID-19 vaccines are in human clinical trials?

In ordinary times, vaccine development, testing and manufacturing is a process that can take several years to complete. In the context of the COVID-19 global pandemic, we are in far from ordinary times. Extreme efforts are underway across the world to create, test and distribute a safe and effective vaccine. Over 140 vaccines for SARS-CoV-2 are under investigation according to the World Health Organization. As of August 6, there are 26 vaccine candidates in human clinical trials, which are the following: 1. ChAdOx1 nCov-19: Phase I/II,III ChAdOx1 nCoV-19, a recombinant adenovirus vaccine developed by the University of Oxford, entered human clinical trials back in April in the UK. The Phase I/II trial enrolled > 1000 healthy volunteers and aimed to test the safety and immune response triggered by the vaccine. On July 20, the results of the Phase I/II trial were published in The Lancet. They demonstrate that the candidate vaccine was able to...